DK1851198T3 - Substituerede pyrroler, sammensætninger, der indeholder dem, fremgangsmåde til fremstilling og anvendelse heraf - Google Patents

Substituerede pyrroler, sammensætninger, der indeholder dem, fremgangsmåde til fremstilling og anvendelse heraf

Info

Publication number
DK1851198T3
DK1851198T3 DK06709274T DK06709274T DK1851198T3 DK 1851198 T3 DK1851198 T3 DK 1851198T3 DK 06709274 T DK06709274 T DK 06709274T DK 06709274 T DK06709274 T DK 06709274T DK 1851198 T3 DK1851198 T3 DK 1851198T3
Authority
DK
Denmark
Prior art keywords
preparation
methods
compositions containing
pyrrols
substituted
Prior art date
Application number
DK06709274T
Other languages
Danish (da)
English (en)
Inventor
Baptiste Ronan
Michel Tabart
Catherine Souaille
Fabrice Viviani
Eric Bacque
Jean-Philippe Lettalec
Pascal Desmazeau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1851198(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1851198T3 publication Critical patent/DK1851198T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06709274T 2005-02-10 2006-02-08 Substituerede pyrroler, sammensætninger, der indeholder dem, fremgangsmåde til fremstilling og anvendelse heraf DK1851198T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000286 WO2006084996A1 (fr) 2005-02-10 2006-02-08 Pyrroles substitues compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
DK1851198T3 true DK1851198T3 (da) 2009-05-04

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06709274T DK1851198T3 (da) 2005-02-10 2006-02-08 Substituerede pyrroler, sammensætninger, der indeholder dem, fremgangsmåde til fremstilling og anvendelse heraf

Country Status (36)

Country Link
US (1) US7592365B2 (de)
EP (1) EP1851198B1 (de)
JP (1) JP2008530061A (de)
KR (1) KR20070101317A (de)
CN (1) CN101115716A (de)
AR (1) AR052571A1 (de)
AT (1) ATE419234T1 (de)
AU (1) AU2006212106A1 (de)
BR (1) BRPI0606955A2 (de)
CA (1) CA2596822A1 (de)
CR (1) CR9231A (de)
CY (1) CY1108916T1 (de)
DE (1) DE602006004566D1 (de)
DK (1) DK1851198T3 (de)
DO (1) DOP2006000028A (de)
EA (1) EA013060B1 (de)
ES (1) ES2319926T3 (de)
FR (1) FR2881742B1 (de)
GT (1) GT200600048A (de)
HR (1) HRP20090158T1 (de)
IL (1) IL184488A0 (de)
MA (1) MA29248B1 (de)
MX (1) MX2007008789A (de)
MY (1) MY142082A (de)
NO (1) NO20074528L (de)
PA (1) PA8661601A1 (de)
PE (1) PE20061086A1 (de)
PL (1) PL1851198T3 (de)
PT (1) PT1851198E (de)
RS (1) RS50806B (de)
SI (1) SI1851198T1 (de)
TN (1) TNSN07241A1 (de)
TW (1) TW200640858A (de)
UY (1) UY29371A1 (de)
WO (1) WO2006084996A1 (de)
ZA (1) ZA200706157B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
ZA200902715B (en) * 2006-10-23 2010-07-28 Lexicon Pharmaceuticals Inc Process for preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidine-2-ols
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
EP1436279B8 (de) * 2001-09-21 2008-10-29 Smithkline Beecham Corporation Chemische verbindungen
US7307097B2 (en) 2001-09-27 2007-12-11 Smithkline Beechman Corporation Chemical compounds
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
CA2522176A1 (en) * 2003-03-13 2004-09-30 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
MX2007008789A (es) 2007-09-11
IL184488A0 (en) 2007-10-31
TNSN07241A1 (en) 2008-11-21
AU2006212106A1 (en) 2006-08-17
PT1851198E (pt) 2009-03-26
CY1108916T1 (el) 2014-07-02
AR052571A1 (es) 2007-03-21
BRPI0606955A2 (pt) 2009-07-28
WO2006084996A1 (fr) 2006-08-17
US7592365B2 (en) 2009-09-22
MY142082A (en) 2010-08-30
EP1851198A1 (de) 2007-11-07
CN101115716A (zh) 2008-01-30
HRP20090158T1 (en) 2009-05-31
EP1851198B1 (de) 2008-12-31
RS50806B (sr) 2010-08-31
ATE419234T1 (de) 2009-01-15
DOP2006000028A (es) 2006-09-15
CA2596822A1 (fr) 2006-08-17
TW200640858A (en) 2006-12-01
ES2319926T3 (es) 2009-05-14
SI1851198T1 (sl) 2009-06-30
UY29371A1 (es) 2006-10-02
JP2008530061A (ja) 2008-08-07
EA200701688A1 (ru) 2007-12-28
PA8661601A1 (es) 2006-09-08
PL1851198T3 (pl) 2009-06-30
US20080167368A1 (en) 2008-07-10
FR2881742B1 (fr) 2007-09-07
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
EA013060B1 (ru) 2010-02-26
NO20074528L (no) 2007-10-31
ZA200706157B (en) 2008-11-26
FR2881742A1 (fr) 2006-08-11
DE602006004566D1 (de) 2009-02-12
PE20061086A1 (es) 2006-11-30
CR9231A (es) 2007-10-23
GT200600048A (es) 2006-07-03

Similar Documents

Publication Publication Date Title
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK1896364T3 (da) Pulverformet kalksammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1756064T3 (da) Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
NO20200670A1 (no) Sammensetninger og fremgangsmåter for modulering av hemostase
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1858488T4 (da) Tigecyclinsammensætninger og fremgangsmåder til fremstilling deraf
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
DK1891208T3 (da) Hidtil ukendte cellulære sammensætninger og fremgangsmåder til fremstilling deraf
DK1845978T3 (da) Substituerede pyrazolopyridiner, sammensætninger, som indeholder disse, fremgangsmåde til fremstilling heraf, og anvendelse heraf
DK1713806T3 (da) Forbindelser og sammensætninger som proteinkinaseinhibitorer
DK1901731T3 (da) Niacinreceptoragonister, sammensætninger indeholdende sådanne forbindelser og fremgangsmåder til behandling
DK3078417T3 (da) Bulk-katalysatorsammensætning og fremgangsmåde til at fremstille den
DK2021328T3 (da) Forbindelser og sammensætninger som hedgehog (pindsvin)-signalvejsmodulatorer
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
DK3305776T3 (da) Pyrrol-forbindelser som inhibitorer af erk-protein-kinaser og farmaceutiske sammensætninger, der indeholder disse forbindelser
DK1922309T3 (da) N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf
DK1948149T3 (da) Præparat indeholdende metformin og vildagliptin
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
IL191137A0 (en) Polycation-polyanion complexes, compositions and methods of use thereof
DK2019090T3 (da) Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf
DK2125788T3 (da) Heterocykliske forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
DK2152663T3 (da) Tri-aryl-forbindelser og sammensætninger, der omfatter dem
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse